PWP
TNYA icon

Parkwoods Wealth Partners’s Tenaya Therapeutics TNYA Stock Holding History

Parkwoods Wealth Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Buy
17,800
+800
+5% +$590 ﹤0.01% 111
2025
Q4 		$12.1K Buy
17,000
+2,000
+13% +$2.72K ﹤0.01% 108
2025
Q3 		$24.3K Buy
+15,000
New +$15.1K 0.01% 96

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkwoods Wealth Partners's TNYA Position: Q1 2026 in Review

Parkwoods Wealth Partners increased its Tenaya Therapeutics (TNYA) stake by 4.7% in Q1 2026, buying an estimated $590 and bringing the position to 17,800 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #111.

Parkwoods Wealth Partners first reported a position in TNYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $24.3K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Parkwoods Wealth Partners held 17,800 shares of Tenaya Therapeutics worth $12.3K as of Q1 2026.
  • Parkwoods Wealth Partners bought 800 Tenaya Therapeutics shares in Q1 2026, an estimated $590.
  • Tenaya Therapeutics made up ﹤0.01% of Parkwoods Wealth Partners's portfolio in Q1 2026, its #111 holding.
  • Parkwoods Wealth Partners first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Parkwoods Wealth Partners's Tenaya Therapeutics position peaked at $24.3K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Parkwoods Wealth Partners's 13F filing for Q1 2026, filed 13 Apr 2026.